144 related articles for article (PubMed ID: 34993032)
1. Erythrodysesthesia: An Unusual Complication With Trastuzumab Monotherapy.
Fontenot AL; Furr WJ; Husan A; Khan MW
Cureus; 2021 Nov; 13(11):e20060. PubMed ID: 34993032
[TBL] [Abstract][Full Text] [Related]
2. Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).
Templeton AJ; Ribi K; Surber C; Sun H; Hsu Schmitz SF; Beyeler M; Dietrich D; Borner M; Winkler A; Müller A; von Rohr L; Winterhalder RC; Rochlitz C; von Moos R; Zaman K; Thürlimann BJ; Ruhstaller T;
Breast; 2014 Jun; 23(3):244-9. PubMed ID: 24656636
[TBL] [Abstract][Full Text] [Related]
3. Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment.
Farr KP; Safwat A
Case Rep Oncol; 2011 Apr; 4(1):229-35. PubMed ID: 21537373
[TBL] [Abstract][Full Text] [Related]
4. An exploratory study to identify risk factors for the development of capecitabine-induced Palmar Plantar Erythrodysesthesia (PPE).
Law A; Dyson S; Anthony D
J Adv Nurs; 2015 Aug; 71(8):1825-32. PubMed ID: 25702709
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-associated palmar-plantar erythrodysesthesia: a case report and review of the literature.
Harris CS; Wang D; Carulli A
J Oncol Pharm Pract; 2014 Feb; 20(1):73-80. PubMed ID: 23478198
[TBL] [Abstract][Full Text] [Related]
6. Palmar-plantar erythrodysesthesia secondary to docetaxel chemotherapy: a case report.
Benghiat H; Al-Niaimi A
J Med Case Rep; 2011 Feb; 5():80. PubMed ID: 21352522
[TBL] [Abstract][Full Text] [Related]
7. Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report.
Hu HP; Corkum MT; Perera F
Cureus; 2018 Dec; 10(12):e3704. PubMed ID: 30788193
[TBL] [Abstract][Full Text] [Related]
8. Anticancer drug induced palmar plantar erythrodysesthesia.
Palaniappan M; Srinivasamurthy S; Dubashi B; Chandrasekaran A
J Clin Diagn Res; 2014 Oct; 8(10):HC01-3. PubMed ID: 25478366
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-Induced Palmar-Plantar Erythrodysesthesia.
Wahab A; Khakwani M; Ehsan H; Bellam N
Cureus; 2020 Nov; 12(11):e11507. PubMed ID: 33214972
[TBL] [Abstract][Full Text] [Related]
10. Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome).
Lorusso D; Di Stefano A; Carone V; Fagotti A; Pisconti S; Scambia G
Ann Oncol; 2007 Jul; 18(7):1159-64. PubMed ID: 17229768
[TBL] [Abstract][Full Text] [Related]
11. Clinical risk factors of PEGylated liposomal doxorubicin induced palmar plantar erythrodysesthesia in recurrent ovarian cancer patients.
Ko EM; Lippmann Q; Caron WP; Zamboni W; Gehrig PA
Gynecol Oncol; 2013 Dec; 131(3):683-8. PubMed ID: 24096112
[TBL] [Abstract][Full Text] [Related]
12. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.
Webster-Gandy JD; How C; Harrold K
Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337
[TBL] [Abstract][Full Text] [Related]
13. Palmar-plantar erythrodysesthesia associated with high-dose methotrexate: Case report.
Chauhan P; Gupta A; Kumar S; Bishnu A; Nityanand S
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1270. PubMed ID: 32767666
[TBL] [Abstract][Full Text] [Related]
14. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia.
Lopez AM; Wallace L; Dorr RT; Koff M; Hersh EM; Alberts DS
Cancer Chemother Pharmacol; 1999; 44(4):303-6. PubMed ID: 10447577
[TBL] [Abstract][Full Text] [Related]
15. A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance.
Teymouri F; Dasanu CA
J Oncol Pharm Pract; 2024 May; ():10781552241258175. PubMed ID: 38813782
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies.
Clark AS; Vahdat LT
Support Cancer Ther; 2004 Jul; 1(4):213-8. PubMed ID: 18628145
[TBL] [Abstract][Full Text] [Related]
17. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
Kara IO; Sahin B; Erkisi M
Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
[TBL] [Abstract][Full Text] [Related]
18. Severe palmar-plantar erythrodysesthesia and aplasia in an adult undergoing re-induction treatment with high-dose cytarabine for acute myelogenous leukemia: a possible drug interaction between posaconazole and cytarabine.
Alzghari SK; Seago SE; Cable CT; Herrington JD
J Oncol Pharm Pract; 2017 Sep; 23(6):476-480. PubMed ID: 27530244
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.
Chalermchai T; Tantiphlachiva K; Suwanrusme H; Voravud N; Sriuranpong V
Asia Pac J Clin Oncol; 2010 Sep; 6(3):155-60. PubMed ID: 20887495
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]